Title: Maternal and fetal Outcomes Associated with Pre-Eclampsia Patients
Authors: Hind Basheer Sulayman Karawad, Abdurrahman. J. Asharef, and Azab Elsayed Azab
Volume: 9
Issue: 1
Pages: 92-105
Publication Date: 2025/01/28
Abstract:
Background: Pre-eclampsia, more than being proteinuric gestational hypertension alone, is a state of exaggerated systemic inflammation and remains a leading direct cause of maternal morbidity and mortality worldwide. Reduction of the burden of illness associated with pre-eclampsia will address in part the aims of Millennium Development Goal. In high-income countries, this excess maternal morbidity and mortality relates to both uncontrolled hypertension and the pulmonary and hepatic consequences of systemic inflammation. The only cure for pre-eclampsia is delivery. For pre-eclampsia arising remote from term, supportive and temporising measures (expectant management) are used to improve perinatal outcomes. Objectives: The present study aimed to evaluate the maternal and fetal outcome among the mothers with preeclampsia. Materials and Methods: This was retrospective descriptive case series study. It conducted in Aljala hospital Tripoli/Libya during the year 2015-2016. One hundred women were selected, all the cases were diagnosed as patients with pre-eclampsia, and all the cases were selected from the hospital files. The following data was obtained from the files: the age, gravidity, parity, abortion history, onset of pre-eclampsia, history of pre-eclampsia, past medical history, family history of pre-eclampsia, evaluation of pre-eclampsia, maternal complications, mode of delivery, placental location, neonatal sex, Apgar score, birth weight, and fetal and neonatal complication. Result: The mean age for the patients was (34.48 ± 5.9 years). The maximum age of the patients was 46 years and the minimum age was 18years.The majority of preeclampsia patients (57%) aged from 31 up to 40 years, 74% of cases were diagnosed after 34 weeks of gestation. About 52% of mothers didn't receive any treatment. About 12% of cases had preterm delivery, 8% abruption placenta and 10% of mothers admitted to the ICU after delivery, 2 cases with HELP syndrome and 4 elclamptic cases and only 1 woman died after delivery. The percentage of dead babies was 2%. Approximately 75% of the newborn had normal weight. Around 14% of the newborns admitted to the neonatal ICU. Conclusion: Eclampsia is still a major threat to the pregnant woman in our institution and it was the leading cause of maternal mortality in last 2 years. To improve maternal and perinatal outcome the awareness for antenatal care, early diagnosis and referrals is needed. Further, providing ICU/Nursing care will help to reduce maternal/perinatal morbidity and mortality.